
Dr. Larissa Derzko-Dzulynsky
Participates in 5 items
Dr. Derzko-Dzulynsky completed her undergraduate and medical degrees at the University of Toronto, followed by fellowship training in uveitis at McGill University and post-fellowship training in retina and uveitis at the U of T Department of Ophthalmology and Vision Sciences (DOVS). Dr. Derzko-Dzulynsky was appointed Lecturer in the DOVS in 2000, promoted to Assistant Professor in 2008 then to her current position as Chief of the Uveitis Service in 2013. In addition, she is on staff at St. Joseph’s Health Centre, Kensington Eye Institute and St. Michael’s Hospital.
Dr. Derzko-Dzulynsky actively participates in resident clinical and surgical teaching in the DOVS. Research activities have included a resident-led quality-improvement project on wait times for uveitis consults in Toronto, and a study on clinical features of infectious posterior uveitis at St. Michael’s Hospital. She recently published on cataract surgery outcomes in uveitis and IgG4 panuveitis. Dr. Derzko-Dzulynsky is primary investigator on a resident-led multidisciplinary and translational research project on PCR utilization in anterior uveitis cases, which was awarded a grant from the DOVS Pilot Research Grant Competition in December 2016.
Dr. Derzko-Dzulynsky participated on an Ontario Task Force for Uveitis Care that established standardized criteria for immunomodulatory treatment for uveitis (MOHTLC Exceptional Access Program) and developed a standardized communication tool for use between ophthalmologists and rheumatologists. This tool will be used for a new Uveitis Registry in Ontario, which Dr. Derzko-Dzulynsky will be launching with the Task Force for Uveitis Care. She was President of the Canadian Uveitis Society from 2010-2013, during which time she worked closely with the Canadian Ophthalmological Society and the Ontario Rheumatology Association to increase awareness of uveitis at the provincial and federal government levels. She has also been the Canadian representative at the International Ocular Inflammation Society since 2013.
Dr. Derzko-Dzulynsky enjoys various sports and outdoor activities including cycling and skiing, as well as spending time with her family. She has raised funds for The Foundation Fighting Blindness through her participation in Cycle for Sight.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
1. Abbvie
2. Amgen
3. Gilead
4. Santen, Inc.
Dr. Derzko-Dzulynsky actively participates in resident clinical and surgical teaching in the DOVS. Research activities have included a resident-led quality-improvement project on wait times for uveitis consults in Toronto, and a study on clinical features of infectious posterior uveitis at St. Michael’s Hospital. She recently published on cataract surgery outcomes in uveitis and IgG4 panuveitis. Dr. Derzko-Dzulynsky is primary investigator on a resident-led multidisciplinary and translational research project on PCR utilization in anterior uveitis cases, which was awarded a grant from the DOVS Pilot Research Grant Competition in December 2016.
Dr. Derzko-Dzulynsky participated on an Ontario Task Force for Uveitis Care that established standardized criteria for immunomodulatory treatment for uveitis (MOHTLC Exceptional Access Program) and developed a standardized communication tool for use between ophthalmologists and rheumatologists. This tool will be used for a new Uveitis Registry in Ontario, which Dr. Derzko-Dzulynsky will be launching with the Task Force for Uveitis Care. She was President of the Canadian Uveitis Society from 2010-2013, during which time she worked closely with the Canadian Ophthalmological Society and the Ontario Rheumatology Association to increase awareness of uveitis at the provincial and federal government levels. She has also been the Canadian representative at the International Ocular Inflammation Society since 2013.
Dr. Derzko-Dzulynsky enjoys various sports and outdoor activities including cycling and skiing, as well as spending time with her family. She has raised funds for The Foundation Fighting Blindness through her participation in Cycle for Sight.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
1. Abbvie
2. Amgen
3. Gilead
4. Santen, Inc.
Sessions in which Dr. Larissa Derzko-Dzulynsky participates
الخميس 31 مايو, 2018
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
الجمعة 1 يونيو, 2018
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
Non-Infectious Uveitis: What's best for my patient: Local or systemic treatment?
6:30 -
8:00 |
1 hour 30 minutes
Immunosuppression for uveitis: What, when, how, and by whom?
7:20 -
7:33 |
13 minutes
الجمعة 16 يونيو, 2023
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
Sessions in which Dr. Larissa Derzko-Dzulynsky attends
الجمعة 10 يونيو, 2022
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
Current Concepts I
7:00 -
9:00 |
2 hours
- Dr. Mona Harissi-Dagher (Moderator)
- Alan McNab (Keynote speaker)
- Marcia Anderson (Keynote speaker)
- Sander Dubovy (Keynote speaker)
- Carol Shields MD (Keynote speaker)
- Dr. Cindy M. L. Hutnik, MD, PhD (Presenter)
- Thuy Doan MD, PhD (Keynote speaker)
- Dr. Nupura Bakshi (Moderator)
- Navdeep Nijhawan MD, FRCSC, DABO (Moderator)
- Dr. Colin Mann (Speaker)
- Dr. Jim Farmer, MD, FRCSC, FRCPC (Moderator)
- Anuradha Mishra MD, MEd (Speaker)
STC: Technologies & Public and Global Eye Health Research
9:45 -
11:15 |
1 hour 30 minutes
What's new in uveitis?
9:45 -
11:15 |
1 hour 30 minutes
الخميس 15 يونيو, 2023
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
SCO SFO Symposium
13:30 -
15:40 |
2 hours 10 minutes
الجمعة 16 يونيو, 2023
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
Current Concepts I
8:00 -
10:00 |
2 hours
- Dr. Nupura Bakshi (Moderator)
- Dr. Jim Farmer, MD, FRCSC, FRCPC (Moderator)
- Dr. Mona Harissi-Dagher (Moderator)
- Dr. Jacinthe Rouleau (Moderator)
- Phil Hooper MD (Speaker)
- Thomas J. Cummings, MD (Keynote speaker)
- Santosh Honavar, MD (Keynote speaker)
- Dr. Lynn Gordon (Keynote speaker)
- Dr. Saroo Sharda (Keynote speaker)
Cataract II: Multidisciplinary considerations in cataract surgery
13:30 -
15:00 |
1 hour 30 minutes